Universal weekly testing as the UK COVID-19 lockdown exit strategy

The British public have been offered alternating periods of lockdown and relaxation of restrictions as part of the coronavirus disease 2019 (COVID-19) lockdown exit strategy.1 Extended periods of lockdown will increase economic and social damage, and each relaxation will almost certainly trigger a f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2020-05, Vol.395 (10234), p.1420-1421
Hauptverfasser: Peto, Julian, Alwan, Nisreen A, Godfrey, Keith M, Burgess, Rochelle A, Hunter, David J, Riboli, Elio, Romer, Paul, Buchan, Iain, Colbourn, Tim, Costelloe, Céire, Davey Smith, George, Elliott, Paul, Ezzati, Majid, Gilbert, Ruth, Gilthorpe, Mark S, Foy, Robbie, Houlston, Richard, Inskip, Hazel, Lawlor, Deborah A, Martineau, Adrian R, McGrath, Nuala, McCoy, David, Mckee, Martin, McPherson, Klim, Orcutt, Miriam, Pankhania, Bharat, Pearce, Neil, Peto, Richard, Phillips, Andrew, Rahi, Jugnoo, Roderick, Paul, Saxena, Sonia, Wilson, Ann, Yao, Guiqing Lily
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The British public have been offered alternating periods of lockdown and relaxation of restrictions as part of the coronavirus disease 2019 (COVID-19) lockdown exit strategy.1 Extended periods of lockdown will increase economic and social damage, and each relaxation will almost certainly trigger a further epidemic wave of deaths. There is an alternative strategy: universal repeated testing.2 We recommend evaluation of weekly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen testing of the whole population in an entire city as a demonstration site (preferably several towns and cities, if possible), with strict household quarantine after a positive test. PCR reagents should be obtained from manufacturers, rather than clinical test companies, and exempt from regulatory requirements on medical testing to limit costs and ensure supplies.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(20)30936-3